These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21969170)

  • 21. Combined oral contraceptives: acceptability and effective use.
    Kubba A; Guillebaud J
    Br Med Bull; 1993 Jan; 49(1):140-57. PubMed ID: 8324604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of contraceptive use in Jos University Teaching Hospital, north central Nigeria.
    Mutihir JT; Pam VC
    Niger J Clin Pract; 2008 Jun; 11(2):139-43. PubMed ID: 18817054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations.
    Belsey EM; Peregoudov S
    Contraception; 1988 Aug; 38(2):227-42. PubMed ID: 2971507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Family planning through private practitioners: characteristics of Kenyan contraceptive acceptors.
    Rogo KO
    Int J Gynaecol Obstet; 1990 Jan; 31(1):47-55. PubMed ID: 1968018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contraception for the older woman.
    Guillebaud J
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S70-7. PubMed ID: 12268772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.
    Abasiattai AM; Udoma EJ; Ukeme E
    Ann Afr Med; 2010; 9(2):81-5. PubMed ID: 20587929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the October 1995 pill scare in Grampian.
    Flett G; Gurney E; McKessock L; Reid J
    Br J Fam Plann; 1998 Apr; 24(1):18-20. PubMed ID: 9719702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from an audit of unplanned pregnancies.
    Metson D
    BMJ; 1988 Oct; 297(6653):904-6. PubMed ID: 3140975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New IPPF statement on breastfeeding, fertility and post-partum contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of rigevidon for oral contraception in a family planning clinic in Kota Bahru, Kelantan.
    Ang Eng Suan ; Karim HA
    Malays J Reprod Health; 1990 Jun; 8(1):31-7. PubMed ID: 12316342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contraceptive use at the family planning clinic of the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ozumba BC; Ibekwe PC
    Public Health; 2001 Jan; 115(1):51-3. PubMed ID: 11402352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilisation of family planning services at the teaching hospital in Blantyre, Malawi.
    Lema VM; Mtimavalye LA; Gondwe EE
    East Afr Med J; 1994 Nov; 71(11):703-11. PubMed ID: 7859653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of family planning clients in Bangladesh.
    Swenson I; Khan AR
    Int J Fertil; 1983; 28(3):149-55. PubMed ID: 6140233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with a triphasic oral contraceptive.
    Ulstein M; Svendsen E; Steier A; Bratt H; Fylling P; Lie S; Schiefloe A; Aaserud J
    Acta Obstet Gynecol Scand; 1984; 63(3):233-6. PubMed ID: 6428157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
    Belsey EM
    Contraception; 1988 Aug; 38(2):207-25. PubMed ID: 2971506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
    Paoletti AM; Orrù M; Floris S; Mannias M; Vacca AM; Ajossa S; Guerriero S; Melis GB
    Contraception; 2000 Apr; 61(4):259-63. PubMed ID: 10899481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.